Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

The 3D skin model mimics pemphigus vulgaris and helps test treatments.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

CS12192 effectively treats alopecia areata with better safety than current options.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Recent advances show zebrafish can model anemia, Alx4 affects craniofacial and hair development, and mTORC1 is crucial for retinal development.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Frunevetmab injections in cats can cause severe itching and skin lesions.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.